Recent Security Class Actions

PepGen Inc. Common Stock (NASDAQ: PEPG)

44 Days left to seek lead plaintiff status.

Company Name:PepGen Inc. Common Stock
Stock Symbol:NASDAQ: PEPG
Class Period Start:03/07/2024
Class Period End (inclusive):03/03/2025
Filing Deadline:08/08/2025

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) PGN-EDO51 was less effective and safe than Defendants had led investors to believe; (ii) the CONNECT2 study was dangerous or otherwise deficient for purposes of U.S. Food and Drug Administration ("FDA") approval; (iii) as a result of all the foregoing, PepGen was likely to halt the CONNECT2 study, and PGN-EDO51's clinical, regulatory, and commercial prospects were overstated; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.

PepGen Inc. Common Stock (NASDAQ: PEPG) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.